Acta Med. 1999, 42: 97-101
https://doi.org/10.14712/18059694.2019.151
Serum Soluble Adhesion Molecules (sICAM-1, sVCAM-1, sE-selectin) and Neopterin in Patients with Sjögren's Syndrome
References
1. J Rheumatol 1999; 22:1152-8.
JM, Ogawa N, Talal N. Sjögren's syndrome in childhood.
2. Hum Pathol 1988; 19:932-40.
< RE, Hagen KA, Manivel JC. Distribution and immunophenotype of the inflammatory cell population in the benign lymphoepithelial lesions (Mikulicze's disease). https://doi.org/10.1016/S0046-8177(88)80009-1>
3. Clin Rheumatol 1995; 14:S1,44.
KE, McCluskey PJ, Wakefield D. Epithelial and endothelial cell expression of surface adhesion molecules and their ligands in labial salivary glands from patients with Sjögren's syndrome.
4. Br J Cancer 1993; 68:122-4.
< RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. https://doi.org/10.1038/bjc.1993.298>
<PubMed>
5. Thromb Haemost 1994; 72:151-4.
AD, Collum ChN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.
6. Immunol Today 1995; 16:251-2.
< AD, McCollum ChN, Steiner M, Jayson MIV. Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. https://doi.org/10.1016/0167-5699(95)80169-3>
7. Blood 1994; 84:2068-101.
TM, Harlan JM. Leukocyte-endothelial adhesion molecules.
8. J Rheumatol 1993; 20:809-14.
CW, Beall LD, Hunder GG, Johnson CHM, Newman W. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus.
9. Br J Dermatol 1996; 134:17-21.
< W, Schopf E, Kapp A. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis. Correlation with disease activity. https://doi.org/10.1111/j.1365-2133.1996.tb07833.x>
10. Arthritis-Rheum. 1997; 40(7):1250-6.
< OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. https://doi.org/10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A>
11. Scand J Immunol 1993; 38:158-66.
< C, Thiele HG, Hamann A. Lymphocyte-endothelial interactions in inflamed synovia: Involvement of several adhesion molecules and integrin epitopes. https://doi.org/10.1111/j.1365-3083.1993.tb01708.x>
12. Ann Rheum Dis 1997; 56:41-4.
< RM, Cardon T, Copin MC, et al. ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis. https://doi.org/10.1136/ard.56.1.41>
<PubMed>
13. Int Arch Allergy Immunol 1993; 101:1-6.
< D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. https://doi.org/10.1159/000236491>
14. Ann N Y Acad Sci 1992; 667:324-31.
< AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-Selectin, ICAM-1 and VCAM-1: Pathological significance. https://doi.org/10.1111/j.1749-6632.1992.tb51633.x>
15. Immunol Today 1993; 14:506-12.
< AJH, Newman W. Circulating adhesion molecules in disease. https://doi.org/10.1016/0167-5699(93)90267-O>
16. Immunol Today 1994; 15:251-5.
< A. The role of cell adhesion molecules in immunopathology. https://doi.org/10.1016/0167-5699(94)90002-7>
17. J Immunol 1992; 149:4082-7.
KJ, Ginther Luce GE, Tanaka Y et al. Differential expression of VLA-4 and VLA beta1 discriminates multiple subsets of CD4+CD45RO+ "memory" T cells.
18. Clin Rheumatol 1995; 14:S1,44.
AC, Cuida M, Halse AK, Jonsson R. Soluble adhesion molecules in saliva and plasma of patients with primary Sjögren's syndrome.
19. Curr Opin Immunol 1995; 4:657-65.
L., De Wilde P.C.M. 1992. New developments in Sjögren's syndrome.
20. Clin Rheumatol 1997; 16:149-53.
< J, Slezak R, Kopecky O, Derner V, Andrys C. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome. https://doi.org/10.1007/BF02247843>
21. J Immunol 1995; 155:525-8.
K, Tedder TF. Leukocyte interactions with vascular endothelium.
22. Clin Immunol Immunopathol 1996; 97:211-6.
< JS, Liu MF, Lei HY. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: A potential marker for disease activity. https://doi.org/10.1006/clin.1996.0070>
23. Sb Ved Pr Lek Fak UK Hradec Králové 1993; 36:149-55.
B, Lukeš J, Malíř F, Tichý M. Neopterin in the diagnosis of disorders associated with immune system activation.
24. Moutsopoulos HM, Tzioufas AG. Sjögren's syndrome. In: Klippel JH, Dieppe PA. Rheumatology. Mosby,1994:section 6:27.1-27.12.
25. Ter-Arkh 1998; 70(5):28-31.
EL, Samsonov MI, Chichasova NV et al. Neopterin: laboratory marker of cellular immunity activation in rheumatoid arthritis (in russian).
26. J Immunol 1993; 150:644-54.
W, Beall LD, Carson CW et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock.
27. Nature 1991; 349:796-9.
< LJ, Kishimoto TK, Smith CV et al. ELAM-1 is an adhesion molecule for skin-homing T cells. https://doi.org/10.1038/349796a0>
28. Arth Rheum 1986; 29:1063-70.
< G, Egg D, Fuchs D et al. Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. https://doi.org/10.1002/art.1780290902>
29. Cancer Detect Prev 1991; 15:383-490.
G, Fuchs D, Fuith LC et al. Neopterin as a marker for activated cellmediated immunity: Application in malignant disease.
30. Int. Ophtalm Clinics 1994; 34:137-43.
< I. Possible mechanism of cellular activation and tissue destruction in Sjögren's syndrome. https://doi.org/10.1097/00004397-199403410-00013>
31. J Clin Lab Analysis 1993; 7:180-7.
< I, Tarauch K, Shimuta M et al. Expression of cell adhesion molecules in the salivary and lacrimal gland of Sjögren's syndrome. https://doi.org/10.1002/jcla.1860070309>
32. Lancet 1991; 338:83-4.
< R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. https://doi.org/10.1016/0140-6736(91)90077-3>
33. Nature 1991; 349:799-802.
< Y, Shaw S, Graber N et al. Activation independent binding of human memory T cells to adhesion molecule ELAM-1. https://doi.org/10.1038/349799a0>
34. Clin Exp Immunol 1994; 97:439-44.
< PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CGM. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. https://doi.org/10.1111/j.1365-2249.1994.tb06107.x>
<PubMed>
35. Concepts Immunopathol 1992; 8:161-88.
EW. Sjögren's syndrome and autoimmunity.
36. Leukemia 1996; 10:682-6.
T, Wehmeier A, Kliche KO et al. Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia.
37. Clin Exp Immunol 1993; 93:292-8.
< EME, Beekhuizen H, Blokland I, vanFurth R. Increased adhesion of human monocytes to IL-4 stimulated human venous endothelial cells via CD11/CD18, and very late antigen 4 (VLA-4)/vascular cell adhesion molecule-1 (VCAM-1)-dependent mechanisms. https://doi.org/10.1111/j.1365-2249.1993.tb07982.x>
<PubMed>
38. Arthritis Rheum 1993; 6:340-7.
< C, Bombardieri S, Haralampos M et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. https://doi.org/10.1002/art.1780360309>
39. Adv Clin Chem 1989; 27:81-141.
< H, Fuchs D, Hausen A et al. Neopterin as marker for activation of cellular immunity : immunological basis and clinical applications. https://doi.org/10.1016/S0065-2423(08)60182-1>
40. J Leukoc Biol 1996; 59:789-96.
< SM, Feldman GM, McCarthy JB. Regulation of leukocyte adhesion and signaling in inflammation and disease. https://doi.org/10.1002/jlb.59.6.789>